Acclaimed singer and performer Adam Lambert has been cast in the role of Judas Iscariot in the Hollywood Bowl’s upcoming production of Jesus Christ Superstar, slated for August 2025.
The announcement, which has drawn attention both in the entertainment industry and among faith communities, places Lambert in one of the most iconic and controversial roles in musical theater. According to The Christian Post, the production will feature a modern staging of Andrew Lloyd Webber and Tim Rice’s 1970 rock opera, which has long sparked conversation for its dramatic portrayal of the final days of Jesus Christ—told largely through the perspective of Judas.
Lambert, known for his rise on American Idol and subsequent international success as the frontman for Queen + Adam Lambert, has previously expressed openness about his sexuality and spirituality. This has fueled discussion online regarding his casting, with some Christian audiences voicing concern over the symbolic implications of the role. According to CP, social media reactions have ranged from enthusiastic support of Lambert’s vocal talent to sharp criticism rooted in religious conviction.
Despite the controversy, the production appears set to move forward with a high-profile cast and creative team. The Hollywood Bowl, a prominent venue in Los Angeles with a history of staging major musical revivals, has not yet released full details regarding the director or additional casting.
The rock opera, known for its provocative reinterpretation of Gospel events, continues to stir debate more than 50 years after its debut. While some hail it as a groundbreaking work of art, others challenge its theological liberties. Lambert’s involvement in the 2025 staging is expected to amplify that conversation, especially given his influence in both mainstream pop culture and LGBTQ+ representation.
As of now, Lambert has not made a public statement addressing the backlash or his personal perspective on taking the role. Ticket sales and further announcements are expected in the coming months.
